» Articles » PMID: 16808112

Probiotics and Their Potential Health Claims

Overview
Journal Nutr Rev
Date 2006 Jul 1
PMID 16808112
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Many studies have attempted to identify specific positive health effects of probiotics. One of the challenges in generalizing health effects of probiotics is that different strains exert disparate effects on human health. As a result, the efficacy of one strain or species cannot necessarily be inferred from another. The objective of this review is to examine the current scientific literature that could be used as the basis for potential health claims. More specifically, this paper will review existing evidence of different probiotic strains to prevent and treat diarrhea, treat irritable bowel syndrome (IBS), treat inflammatory bowel disease, and prevent colon cancer. The strongest evidence is related to the use of Lactobacillus rhamnosus GG in the prevention and treatment of rotavirus-associated diarrhea. Further examination of the literature also shows promise in the treatment of some forms of IBS with probiotics. Future studies that use consistent supplementation regimes will allow more definitive conclusions to be drawn on the effects of probiotics on IBS, inflammatory bowel disease, and colon cancer.

Citing Articles

An Updated View of the Effect of Probiotic Supplement on Sports Performance: A Detailed Review.

Aykut M, Erdogan E, Celik M, Gurbuz M Curr Nutr Rep. 2024; 13(2):251-263.

PMID: 38470560 PMC: 11133216. DOI: 10.1007/s13668-024-00527-x.


Effects of probiotics on the oral health of patients undergoing orthodontic treatment: a systematic review and meta-analysis.

Chen W, Ren J, Li J, Peng S, Zhang C, Lin Y Eur J Orthod. 2023; 45(5):599-611.

PMID: 37552088 PMC: 10505686. DOI: 10.1093/ejo/cjad046.


Probiotic therapy, African fermented foods and food-derived bioactive peptides in the management of SARS-CoV-2 cases and other viral infections.

Mgbodile F, Nwagu T Biotechnol Rep (Amst). 2023; 38:e00795.

PMID: 37041970 PMC: 10066861. DOI: 10.1016/j.btre.2023.e00795.


Advances in the development of antivirals for rotavirus infection.

Jiang L, Tang A, Song L, Tong Y, Fan H Front Immunol. 2023; 14:1041149.

PMID: 37006293 PMC: 10063883. DOI: 10.3389/fimmu.2023.1041149.


Evaluation of KAU007 against Low-Pathogenic Avian Influenza Virus (H9N2).

Rather I, Kamli M, Sabir J, Ali S Pathogens. 2022; 11(11).

PMID: 36364997 PMC: 9692965. DOI: 10.3390/pathogens11111246.